Status:

RECRUITING

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Lead Sponsor:

Population Health Research Institute

Collaborating Sponsors:

Hamilton Health Sciences Corporation

Conditions:

Bleeding Post Cardiac Surgery

Indication for Anticoagulation

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The DANCE Trial is a multi-centre, randomized controlled trial comparing the safety of direct oral anticoagulants (DOAC) versus vitamin K antagonists (VKA) in the early period (30 days) after cardiac ...

Detailed Description

Approximately 36,000 Canadian adults undergo cardiac surgery annually. Of these patients, about 10% have a prior history of atrial fibrillation (AF). In the early post-operative period after cardiac s...

Eligibility Criteria

Inclusion

  • Age ≥18 years at the time of enrolment,
  • Open heart surgery in the last 10 days,
  • Atrial fibrillation requiring anticoagulation (including pre-existing or post-operative atrial fibrillation),
  • Informed consent from either the patient or a substitute decision-maker.

Exclusion

  • Mechanical valve replacement,
  • Antiphospholipid syndrome (triple positive),
  • Severe renal failure (Cockcroft-Gault equation; creatinine clearance \<15 ml/min),
  • Known significant liver disease (Child-Pugh classification B and C),
  • Left ventricular thrombus,
  • Ongoing bleeding, hemorrhagic disorders, or bleeding diathesis,
  • Known contraindication for any DOAC or VKA,
  • Women who are pregnant, breastfeeding, or of childbearing potential,
  • Surgery including left ventricular assist device implantation or cardiac transplantation,
  • Previously enrolled in this trial,
  • Follow-up not possible,
  • History of moderate or severe mitral valvular lesion (stenosis or regurgitation) that is not corrected during index cardiac surgery.

Key Trial Info

Start Date :

July 18 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2027

Estimated Enrollment :

3500 Patients enrolled

Trial Details

Trial ID

NCT04284839

Start Date

July 18 2021

End Date

June 1 2027

Last Update

September 29 2025

Active Locations (19)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (19 locations)

1

St Vincent's Hospital Melbourne

Fitzroy, Victoria, Australia, 3065

2

Royal Melbourne Hospital, University of Melbourne

Parkville, Victoria, Australia, 3050

3

University of Alberta Hospital

Edmonton, Alberta, Canada, T6G 2C8

4

University of British Columbia

Vancouver, British Columbia, Canada, V6T 1Z3